160 related articles for article (PubMed ID: 21172013)
1. Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.
Reinholz MM; Eckel-Passow JE; Anderson SK; Asmann YW; Zschunke MA; Oberg AL; McCullough AE; Dueck AC; Chen B; April CS; Wickham-Garcia E; Jenkins RB; Cunningham JM; Jen J; Perez EA; Fan JB; Lingle WL
BMC Med Genomics; 2010 Dec; 3():60. PubMed ID: 21172013
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterisation of formalin-fixed paraffin-embedded (FFPE) breast tumour specimens using a custom 512-gene breast cancer bead array-based platform.
Abramovitz M; Barwick BG; Willis S; Young B; Catzavelos C; Li Z; Kodani M; Tang W; Bouzyk M; Moreno CS; Leyland-Jones B
Br J Cancer; 2011 Nov; 105(10):1574-81. PubMed ID: 22067903
[TBL] [Abstract][Full Text] [Related]
3. Reliable gene expression profiling of formalin-fixed paraffin-embedded breast cancer tissue (FFPE) using cDNA-mediated annealing, extension, selection, and ligation whole-genome (DASL WG) assay.
Iddawela M; Rueda OM; Klarqvist M; Graf S; Earl HM; Caldas C
BMC Med Genomics; 2016 Aug; 9(1):54. PubMed ID: 27542606
[TBL] [Abstract][Full Text] [Related]
4. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
5. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
[TBL] [Abstract][Full Text] [Related]
6. Illumina whole-genome complementary DNA-mediated annealing, selection, extension and ligation platform: assessing its performance in formalin-fixed, paraffin-embedded samples and identifying invasion pattern-related genes in oral squamous cell carcinoma.
Loudig O; Brandwein-Gensler M; Kim RS; Lin J; Isayeva T; Liu C; Segall JE; Kenny PA; Prystowsky MB
Hum Pathol; 2011 Dec; 42(12):1911-22. PubMed ID: 21683979
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling of formalin-fixed, paraffin-embedded familial breast tumours using the whole genome-DASL assay.
Waddell N; Cocciardi S; Johnson J; Healey S; Marsh A; Riley J; da Silva L; Vargas AC; Reid L; ; Simpson PT; Lakhani SR; Chenevix-Trench G
J Pathol; 2010 Aug; 221(4):452-61. PubMed ID: 20593485
[TBL] [Abstract][Full Text] [Related]
8. Automated extraction of DNA and RNA from a single formalin-fixed paraffin-embedded tissue section for analysis of both single-nucleotide polymorphisms and mRNA expression.
Hennig G; Gehrmann M; Stropp U; Brauch H; Fritz P; Eichelbaum M; Schwab M; Schroth W
Clin Chem; 2010 Dec; 56(12):1845-53. PubMed ID: 20947696
[TBL] [Abstract][Full Text] [Related]
9. Analyses and interpretation of whole-genome gene expression from formalin-fixed paraffin-embedded tissue: an illustration with breast cancer tissues.
Kibriya MG; Jasmine F; Roy S; Paul-Brutus RM; Argos M; Ahsan H
BMC Genomics; 2010 Nov; 11():622. PubMed ID: 21059268
[TBL] [Abstract][Full Text] [Related]
10. Droplet digital PCR measurement of HER2 copy number alteration in formalin-fixed paraffin-embedded breast carcinoma tissue.
Belgrader P; Tanner SC; Regan JF; Koehler R; Hindson BJ; Brown AS
Clin Chem; 2013 Jun; 59(6):991-4. PubMed ID: 23358413
[TBL] [Abstract][Full Text] [Related]
11. Quality assessment metrics for whole genome gene expression profiling of paraffin embedded samples.
Mahoney DW; Therneau TM; Anderson SK; Jen J; Kocher JP; Reinholz MM; Perez EA; Eckel-Passow JE
BMC Res Notes; 2013 Jan; 6():33. PubMed ID: 23360712
[TBL] [Abstract][Full Text] [Related]
12. Whole-genome gene expression profiling of formalin-fixed, paraffin-embedded tissue samples.
April C; Klotzle B; Royce T; Wickham-Garcia E; Boyaniwsky T; Izzo J; Cox D; Jones W; Rubio R; Holton K; Matulonis U; Quackenbush J; Fan JB
PLoS One; 2009 Dec; 4(12):e8162. PubMed ID: 19997620
[TBL] [Abstract][Full Text] [Related]
13. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies.
Ross JS; Gay LM; Wang K; Ali SM; Chumsri S; Elvin JA; Bose R; Vergilio JA; Suh J; Yelensky R; Lipson D; Chmielecki J; Waintraub S; Leyland-Jones B; Miller VA; Stephens PJ
Cancer; 2016 Sep; 122(17):2654-62. PubMed ID: 27284958
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a novel RT-qPCR based test for the quantification of HER2 gene expression in breast cancer.
El Hadi H; Abdellaoui-Maane I; Kottwitz D; El Amrani M; Bouchoutrouch N; Qmichou Z; Karkouri M; ElAttar H; Errihani H; Fernandez PL; Bakri Y; Sefrioui H; Moumen A
Gene; 2017 Mar; 605():114-122. PubMed ID: 28039034
[TBL] [Abstract][Full Text] [Related]
15. Quantitative RT-PCR assay of HER2 mRNA expression in formalin-fixed and paraffin-embedded breast cancer tissues.
Park S; Wang HY; Kim S; Ahn S; Lee D; Cho Y; Park KH; Jung D; Kim SI; Lee H
Int J Clin Exp Pathol; 2014; 7(10):6752-9. PubMed ID: 25400755
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the TOP2A gene does not predict high levels of topoisomerase II alpha protein in human breast tumor samples.
Mueller RE; Parkes RK; Andrulis I; O'Malley FP
Genes Chromosomes Cancer; 2004 Apr; 39(4):288-97. PubMed ID: 14978790
[TBL] [Abstract][Full Text] [Related]
17. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection.
Tramm T; Hennig G; Kyndi M; Alsner J; Sørensen FB; Myhre S; Sørlie T; Overgaard J
Virchows Arch; 2013 Dec; 463(6):775-86. PubMed ID: 24100522
[TBL] [Abstract][Full Text] [Related]
18. High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer.
Staaf J; Jönsson G; Ringnér M; Vallon-Christersson J; Grabau D; Arason A; Gunnarsson H; Agnarsson BA; Malmström PO; Johannsson OT; Loman N; Barkardottir RB; Borg A
Breast Cancer Res; 2010; 12(3):R25. PubMed ID: 20459607
[TBL] [Abstract][Full Text] [Related]
19. An international reproducibility study validating quantitative determination of ERBB2, ESR1, PGR, and MKI67 mRNA in breast cancer using MammaTyper®.
Varga Z; Lebeau A; Bu H; Hartmann A; Penault-Llorca F; Guerini-Rocco E; Schraml P; Symmans F; Stoehr R; Teng X; Turzynski A; von Wasielewski R; Gürtler C; Laible M; Schlombs K; Joensuu H; Keller T; Sinn P; Sahin U; Bartlett J; Viale G
Breast Cancer Res; 2017 May; 19(1):55. PubMed ID: 28490348
[TBL] [Abstract][Full Text] [Related]
20. A novel detection methodology for HER2 protein quantitation in formalin-fixed, paraffin embedded clinical samples using fluorescent nanoparticles: an analytical and clinical validation study.
Hicks DG; Buscaglia B; Goda H; McMahon L; Natori T; Turner B; Soukiazian A; Okada H; Nakano Y
BMC Cancer; 2018 Dec; 18(1):1266. PubMed ID: 30563489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
